Sigmaroc’s (SRC) Buy Rating Reiterated at Liberum Capital

Liberum Capital reissued their buy rating on shares of Sigmaroc (LON:SRC) in a report published on Thursday, ThisIsMoney.Co.Uk reports.

Other research analysts also recently issued research reports about the company. Peel Hunt reissued a buy rating and issued a GBX 69.80 ($0.86) price target on shares of Sigmaroc in a report on Tuesday, June 9th. Peel Hunt restated a buy rating on shares of Sigmaroc in a research note on Thursday.

Shares of LON SRC opened at GBX 41 ($0.50) on Thursday. The company has a market capitalization of $104.03 million and a price-to-earnings ratio of 51.25. Sigmaroc has a 1-year low of GBX 0.43 ($0.01) and a 1-year high of GBX 53.65 ($0.66). The company has a debt-to-equity ratio of 58.46, a current ratio of 1.02 and a quick ratio of 0.73. The business has a 50-day moving average of GBX 42.64 and a 200-day moving average of GBX 40.23.

In related news, insider Max Vermoken purchased 25,644 shares of the company’s stock in a transaction dated Thursday, July 30th. The shares were acquired at an average cost of GBX 41 ($0.50) per share, for a total transaction of £10,514.04 ($12,938.76). Also, insider Garth Palmer purchased 26,315 shares of the company’s stock in a transaction dated Tuesday, June 2nd. The shares were bought at an average price of GBX 38 ($0.47) per share, for a total transaction of £9,999.70 ($12,305.81).

About Sigmaroc

SigmaRoc plc invests in and/or acquires projects in the construction materials sector in the United Kingdom, Guernsey, and Jersey. It also produces aggregates and pre-cast concrete, as well as supplies value-added construction materials; and provides shipping logistics, road contracting, and waste recycling services.

Featured Story: What is an inverted yield curve?

Receive News & Ratings for Sigmaroc Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Sigmaroc and related companies with MarketBeat.com's FREE daily email newsletter.